0
0
December 8, 2025
BOSTON — For decades, the daily multivitamin has been a staple in medicine cabinets worldwide—a “nutritional insurance policy” for millions. Yet, the medical community has long debated whether these pills actually deliver measurable health benefits for the average person. Now, a significant new analysis from the large-scale COSMOS trial offers a clearer answer: while multivitamins may not be a magic bullet for everyone, they appear to offer specific, meaningful benefits for older adults with poorer diets and those seeking to maintain healthy blood pressure.
The study, published this week in the American Journal of Hypertension, analyzed data from nearly 9,000 older adults. Researchers found that while a daily multivitamin did not significantly lower the risk of developing high blood pressure (hypertension) for the general population, it provided a protective benefit for specific subgroups—particularly those whose regular diets lacked nutritional quality.
The “One-Size-Fits-One” Discovery
The findings come from a secondary analysis of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), a major randomized clinical trial led by researchers at Mass General Brigham. The team followed 8,905 men and women (aged 60+) who did not have hypertension at the start of the study. Participants were randomly assigned to take either a daily multivitamin (Centrum Silver) or a placebo for a median of 3.4 years.
In the overall group, the difference between the vitamin takers and the placebo group was negligible. However, when researchers peeled back the layers, two clear beneficiaries emerged:
-
Those with Poorer Diets: Participants who entered the study with lower diet quality scores (based on the Mediterranean diet and other healthy eating indices) saw a roughly 19% lower risk of developing hypertension if they took the multivitamin compared to the placebo.
-
Those with Normal Blood Pressure: For participants starting with healthy blood pressure levels, the multivitamin group showed small but statistically significant reductions in systolic and diastolic blood pressure over two years compared to the placebo group.
Expert Perspectives: “Not a One-Size-Fits-All Solution”
The study challenges the binary “do they work or not?” narrative, suggesting that utility depends heavily on an individual’s baseline health and habits.
“Nutrition is one of the cornerstones for controlling blood pressure and hypertension,” said Dr. Rikuta Hamaya, corresponding author and researcher at the Division of Preventive Medicine at Mass General Brigham. “We found that a daily multivitamin might be useful for reducing the risk of hypertension in people with poorer nutritional intake.”
Dr. Howard Sesso, the study’s senior author, emphasized that these findings refine our understanding of supplementation. “Our findings suggest that a daily multivitamin may not be a one-size-fits-all solution for controlling blood pressure but could be beneficial for important subsets of older adults,” Sesso stated.
However, independent health experts continue to urge caution against viewing supplements as a replacement for lifestyle changes. The U.S. Preventive Services Task Force (USPSTF) has historically maintained that there is “insufficient evidence” to recommend multivitamins for the prevention of cardiovascular disease in healthy adults, advising instead that the focus remain on nutrient-dense whole foods.
Dr. Eleanor W., a preventive cardiologist not involved in the study, notes, “This research validates the ‘gap-filling’ theory of multivitamins. They don’t boost you to ‘super-health’ if you’re already thriving, but they may shore up the foundation if your dietary intake is shaky. It does not, however, replace the need for exercise and sodium reduction.”
Context and Implications for Public Health
Hypertension is a “silent killer,” affecting nearly half of adults in the United States and serving as a primary risk factor for heart disease and stroke. The COSMOS trial is unique because of its rigorous design; unlike observational studies that rely on memory, this was a randomized, double-blind, placebo-controlled trial—the gold standard in medical research.
Previous findings from the COSMOS trial had shown that daily multivitamins might slow cognitive aging and reduce lung cancer risk, but results regarding general cardiovascular events were neutral. This new analysis adds a crucial piece to the puzzle, suggesting that blood pressure benefits are likely subtle and preventative rather than therapeutic.
What This Means for You
For the health-conscious consumer, these findings offer a practical decision-making framework:
-
If you have a pristine diet: If you already consume a diet rich in fruits, vegetables, whole grains, and healthy fats (like the Mediterranean diet), a multivitamin may offer diminishing returns regarding blood pressure control.
-
If your diet is inconsistent: For older adults who struggle to meet daily nutritional requirements—whether due to appetite changes, access to fresh food, or lifestyle—a daily multivitamin could be a low-risk, low-cost tool to help mitigate the risk of developing high blood pressure.
-
Prevention vs. Cure: The study highlights potential benefits for maintaining normal blood pressure, rather than reversing established hypertension.
Limitations to Consider
While promising, the study has limitations. The population consisted of older adults, so the results may not apply to younger people. Additionally, the benefits for blood pressure, while statistically significant, were modest. The reduction in pressure was small enough that it would not replace prescribed anti-hypertensive medication for those who already have high blood pressure.
As research continues, the consensus remains grounded in a “food-first” approach, with supplements serving precisely the role their name implies: a supplement to, not a substitute for, a healthy lifestyle.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Primary Study: Hamaya, R., et al. (2025). “Long-Term Effect of Multivitamin Supplementation on Incident Self-Reported Hypertension and Blood Pressure Changes in the COSMOS Trial.” American Journal of Hypertension. DOI: 10.1093/ajh/hpaf224
